Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07510100 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07510100
- Sponsor
- Nanjing IASO Biotechnology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-10
- Primary completion
- 2029-08-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.